← Back to Catalog
Clinician access
Tirzepatide
5mg
Prescription Peptide
For Research Use Only
Not For Human Use
Not For Human Use
Clinician Only
Metabolic & Foundational
Tirzepatide
Tirzepatide is a dual GIP and GLP-1 receptor agonist designed to enhance weight loss, regulate blood sugar, and improve insulin sensitivity. It helps reduce appetite, slow gastric emptying, and promote fat loss while preserving lean muscle mass.
Available Vials
- Delivery
- Subcutaneous Injection
- Starting Dose
- 2.5mg once weekly
- Titration
- Increase by 2.5mg every 2–4 weeks as tolerated
- Maintenance Range
- 5mg–15mg once weekly
- Sourcing
- Compounded in USA
Quantity
Continue Browsing1
More in Metabolic & Foundational
Semaglutide
5mg
Prescription Peptide
For Research Use Only
Not For Human Use
Not For Human Use
Semaglutide
Subcutaneous Injection
Retatrutide
5mg
Prescription Peptide
For Research Use Only
Not For Human Use
Not For Human Use
Retatrutide
Subcutaneous Injection
Cagrilintide
5mg
Prescription Peptide
For Research Use Only
Not For Human Use
Not For Human Use
Cagrilintide
Subcutaneous Injection
Sign in to view full clinical details
Reconstitution, contraindications, clinic pricing, patient handouts, monitoring cadence, and drug interactions are available to verified clinicians.